GMEDHealthcareLarge-Cap

GLOBUS MEDICAL INC Insider Trading Activity

Every SEC Form 4 insider transaction reported for GLOBUS MEDICAL INC (GMED), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are GMED insiders buying or selling?

GLOBUS MEDICAL INC insiders reported 3 open-market buys ($99.8K) and 71 sells ($291.5M) across 74 Form 4 filings — a net selling position of $291.4M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 9, 2026)

Total Form 4 filings
74
SEC EDGAR
Insider filers
16
Insider buys (3)
$99.8K
Insider sells (71)
$291.5M

Insider sentiment

Net selling

Net insider flow of $291.4M in net selling.

Recent GMED insider transactions

DateInsiderRoleTypeSharesPriceValue
Jun 9, 2026David D DavidarDirectorSale25.0K$80.76$2.0M
Feb 27, 2026Kelly HullerEVP, GC, Corporate SecretarySale20.0K$94.50$1.9M
Feb 17, 2026Kelly HullerEVP, GC, Corporate SecretarySale10.0K$87.67$876.7K
Jan 12, 2026Kyle KlineSenior Vice President, CFOSale3.6K$101.10$363.4K
Jan 12, 2026Leslie V NorwalkDirectorSale2.0K$101.10$202.2K
Dec 16, 2025Leslie V NorwalkDirectorSale4.0K$88.85$355.4K
Dec 4, 2025Kyle KlineSenior Vice President, CFOSale18.5K$90.00$1.7M
Nov 28, 2025Kelly HullerSVP, GC, Corporate SecretarySale7.5K$90.00$675.0K
Nov 13, 2025David D DavidarDirectorSale25.0K$86.00$2.2M
Nov 13, 2025Stephen T ZarrilliDirectorSale25.0K$84.29$2.1M
Nov 10, 2025Ann D RhoadsDirectorSale10.0K$81.80$818.0K
Sep 16, 2025Ann D RhoadsDirectorSale10.0K$58.46$584.6K
Mar 4, 2025Ann D RhoadsDirectorSale7.5K$78.68$590.1K
Jan 14, 2025Keith W PfeilCOO, CFOSale14.2K$88.29$1.3M
Dec 4, 2024Kelly HullerSVP, GC, Corporate SecretarySale2.5K$87.00$217.5K
Nov 25, 2024David D DavidarDirectorSale40.0K$85.00$3.4M
Nov 25, 2024Dan LemaitreDirectorSale14.4K$85.00$1.2M
Nov 25, 2024Daniel T ScavillaPresident, CEOSale130.0K$85.00$11.1M
Nov 8, 2024Daniel T ScavillaPresident, CEOSale60.0K$80.02$4.8M
Nov 8, 2024Kelly HullerSVP, GC, Corporate SecretarySale5.0K$81.01$405.1K
Oct 18, 2024David D DavidarDirectorSale50.0K$75.04$3.8M
Sep 17, 2024Ann D RhoadsDirectorSale15.0K$70.36$1.1M
Sep 17, 2024David D DavidarDirectorSale25.0K$70.46$1.8M
Jul 15, 2024Leslie V NorwalkDirectorSale1.0K$70.00$70.0K
May 14, 2024Dan LemaitreDirectorSale63.3K$64.61$4.1M

Showing the 25 most recent of 74 Form 4 filings for GLOBUS MEDICAL INC.

Most active GMED insiders

  • Kelly Huller16 filings
  • David D Davidar10 filings
  • Keith W Pfeil9 filings
  • James R Tobin6 filings
  • Ann D Rhoads4 filings

Ask anything about GMED insider activity

Use Trabud's AI agent to query GLOBUS MEDICAL INC's Form 4 history in plain English — "Show me GMED CEO purchases this year" or compare it against any other ticker.

Open the AI agent

GMED insider trading FAQ

Are GLOBUS MEDICAL INC insiders buying or selling?

Across 74 SEC Form 4 filings, GLOBUS MEDICAL INC (GMED) insiders reported 3 open-market purchases totaling $99.8K and 71 sales totaling $291.5M. That is a net selling position of $291.4M.

How many insiders trade GMED stock?

16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for GLOBUS MEDICAL INC. The most recent filing was accepted on Jun 9, 2026.

Where does Trabud get GMED insider trading data?

All GMED insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content